Drug recall · May 7, 2014
Cetirizine Hydrochloride Chewable Tablets recall
Why: Failed Impurities/Degradation Specifications: out of specification results for impurities/degradation testing for N-Oxide
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Cetirizine Hydrochloride Chewable Tablets, 5 mg, 30 count bottle, OTC Manufactured by Sun Pharma, Gujarat, India, NDC 47335-343-83
- Lots / codes
JKM2067A Exp. 07/14, JKM2068A Exp.10/14, JKM2069A Exp. 01/15, JKM6399A Exp. 04/15
- Quantity
- 128,363 bottles
- Company
- Caraco Pharmaceutical Laboratories, Ltd., Detroit, MI
- Distribution
- Nationwide
- Initiated
- April 9, 2014 · Voluntary: Firm initiated
- Classified
- May 1, 2014
- Reported
- May 7, 2014
- Ended
- October 7, 2014
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cetirizine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.